Aster DM Healthcare Limited submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Ltd regarding capital raising activities of its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited ("Sarjapur Entity").
The disclosure serves as an update to the company's previous communication dated February 26, 2026, and is made pursuant to Regulation 30(7) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Capital Allotment Details
The Board of Directors of Sarjapur Entity, at its meeting held on June 23, 2026, allotted Compulsorily Convertible Preference Shares to identified investors on a preferential basis through private placement:
- 12,00,000 fully paid-up Series A CCPS with face value of Rs. 50 each
- 34,30,000 partly paid-up Series B CCPS with face value of Rs. 50 each (paid-up amount: INR 5 per share)
Conversion Terms
Both Series A and Series B CCPS have a conversion ratio such that each CCPS shall convert into a maximum of up to 5 equity shares of Sarjapur Entity as on the date of allotment (June 23, 2026).
Future Capital Plans
The Sarjapur Entity is actively looking to raise further capital and is in the process of finalizing other investors to whom additional CCPS may be issued in due course (referred to as "Additional Investment").
Ownership Commitment
Aster DM Healthcare Limited confirmed that its shareholding in Sarjapur Entity will not fall below 75% of the share capital on an as-if converted basis, upon conversion of the allotted Series A CCPS, Series B CCPS, and any potential Additional Investment.
The disclosure was signed by Hemish Purushottam, Company Secretary and Compliance Officer (Membership No. A24331) of Aster DM Healthcare Limited, and digitally dated June 23, 2026 at 19:05:56 IST.